StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Nov 2021 17:09:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form NT 10-K GENEREX BIOTECHNOLOGY For: Jul 31 http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+31/19139655.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+31/19139655.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+31/19139655.html Mon, 01 Nov 2021 17:09:00 -0500 GNBT Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html for the full story. http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html Mon, 26 Jul 2021 09:00:00 -0500 GNBT Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html for the full story. http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Corporation+Subsidiary%2C+Olaregen+Therapeutix+Announces+its+Malaysian+Distribution+Partner%2C+Nexgen+Medical%2C+has+gained+approval+for+the+use+of+Excellagen%C2%AE+Wound+Conforming+Matrix/18718569.html Mon, 26 Jul 2021 09:00:00 -0500 GNBT Form 8-K GENEREX BIOTECHNOLOGY For: Jul 22 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+22/18712750.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+22/18712750.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+22/18712750.html Fri, 23 Jul 2021 07:10:00 -0500 GNBT Form 8-K GENEREX BIOTECHNOLOGY For: Jul 15 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+15/18704857.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+15/18704857.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Jul+15/18704857.html Wed, 21 Jul 2021 16:33:00 -0500 GNBT NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html for the full story. http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Tue, 22 Jun 2021 10:17:00 -0500 A.38837244 GNBT NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html for the full story. http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Tue, 22 Jun 2021 10:17:00 -0500 A.38837244 GNBT NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html for the full story. http://www.streetinsider.com/Press+Releases/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Tue, 22 Jun 2021 10:17:00 -0500 A.38837244 GNBT NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html for the full story. http://www.streetinsider.com/Globe+Newswire/NuGenerex+Immuno-Oncology+Secures+%24535+Million+Valuation+from+World-Class+Independent+Valuation+%26amp%3B+Appraisal+Firm/18588716.html Tue, 22 Jun 2021 10:17:00 -0500 A.38837244 GNBT Form 10-Q GENEREX BIOTECHNOLOGY For: Apr 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18583423.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18583423.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18583423.html Mon, 21 Jun 2021 15:09:00 -0500 GNBT Form NT 10-Q GENEREX BIOTECHNOLOGY For: Apr 30 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18557232.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18557232.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++GENEREX+BIOTECHNOLOGY+++++For%3A+Apr+30/18557232.html Mon, 14 Jun 2021 17:01:00 -0500 GNBT Form 8-K GENEREX BIOTECHNOLOGY For: May 10 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+May+10/18406705.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+May+10/18406705.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++GENEREX+BIOTECHNOLOGY+++++For%3A+May+10/18406705.html Wed, 12 May 2021 09:11:00 -0500 GNBT Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html for the full story. http://www.streetinsider.com/Press+Releases/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html Tue, 11 May 2021 09:00:00 -0500 GNBT Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html for the full story. http://www.streetinsider.com/Globe+Newswire/Generex+Biotechnology+Subsidiary+NuGenHealth+Contracts+with+Westside+Medicine+%26amp%3B+Cardiology%2C+Inc.+to+Provide+Remote+Patient+Monitoring+%28RPM%29+Services/18399062.html Tue, 11 May 2021 09:00:00 -0500 GNBT Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets http://www.streetinsider.com/Press+Releases/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html for the full story. http://www.streetinsider.com/Press+Releases/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html Mon, 10 May 2021 09:00:00 -0500 GNBT Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets http://www.streetinsider.com/Globe+Newswire/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html for the full story. http://www.streetinsider.com/Globe+Newswire/Generex+Posts+Recording+of+May+6+Shareholder+Conference+Call+Highlighting+its+Ii-Key+COVID+Complete+Vaccine%E2%84%A2+and+its%C2%A0Go-Forward+Plans+for+Revenue+Producing+Assets/18391337.html Mon, 10 May 2021 09:00:00 -0500 GNBT